PayPal Stock Analysis: The Comeback Is Near!
1 extracted signal · 1 resolved · 0 still active
The Patient InvestorIndependent analyst profile- Source published
- 07 May 2026, 18:41 UTC
- Recorded by Tahlil Plus
- 19 May 2026, 02:53 UTC

AI-generated source summary
The analysis focuses on PayPal (PYPL), noting its significant decline over the past five years, down 81%. Despite recent earnings beats, the stock's performance has been challenged, with a 7.7% drop in the last five days. The presenter highlights positive growth in 'Venmo momentum' and 'branded experiences,' with Venmo seeing double-digit growth for six consecutive quarters and growing faster than other PayPal segments. This suggests a potential shift in focus and valuation towards Venmo. The company's financial guidance for FY26 remains largely consistent, with slight declines expected in transaction margins and roughly flat TMS ex. interest on customer balances. Non-GAAP operating expenses are projected for a -3% growth. Notably, GAAP EPS growth is expected to be mid-single digit. Free cash flow is projected to be around $6 billion, with a forward FCF yield of approximately 15.8%. The company's share buyback program is also highlighted, with about $1 billion allocated to stock-based compensation. The analysis suggests that PayPal might be undervalued, with the potential for its stock price to rebound, particularly if the market recognizes the value of Venmo and the company's financial health, which includes strong free cash flow generation and share repurchases. The current price is $46.66, with a target price of $50 and a failure bound of $44.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Source processing completed
Source analysis and structured extraction completed.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
The Patient Investor
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.
